Pharmaceuticals, Biotechnology and Life Sciences
Recurrent low-grade serous ovarian cancer is a rare cancer with no FDA-approved treatments Ongoing Phase 3 RAMP 301 trial is…
After five years of development, positive results are seen in old dogs in a rigorous placebo-controlled trial performed at a…
– Veklury Was Associated With a Lower Risk of Developing Long-COVID in One Analysis – – Veklury Was Associated With…
Presentation will highlight publicly for the first time preclinical data on Bonum’s lead cLAG3-IL2 program, demonstrating the power of its…
SAN DIEGO–(BUSINESS WIRE)–Boundless Bio, a clinical-stage, next-generation precision oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Obsidian Therapeutics, Inc., a clinical-stage biotechnology company pioneering engineered cell and gene therapies, today announced presentations reporting initial…
– New Positive Clinical Data Demonstrate Momentum on Investigational Once-Daily, Once-Weekly and Twice-Yearly Dosing Strategies – – Key Findings from…
GFH375 (VS-7375), a potential best-in-class oral KRAS G12D (ON/OFF) inhibitor, demonstrated potent anti-tumor activity in pancreatic and colorectal cancer models;…
VANCOUVER, British Columbia–(BUSINESS WIRE)–$ABCL—AbCellera (Nasdaq: ABCL) today announced that its scientists will present four posters with data from its T-cell…
SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo…